Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Florida International University
With
University of California, San Francisco
National Institute on Drug Abuse (NIDA)
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Assigned male at birth
Identifies as male
Age 18 or older
Reads and speaks English
Reports condomless anal sex (CAS) with men in the past 6 months
self-reported HIV negative
Active prescription for daily oral PrEP for at least 2 months and reports any non-adherence in the past month OR initiated daily oral PrEP in the past 2 months, regardless of self-reported adherence
Has an iPhone or Android smartphone
Screens positive for a moderate or severe stimulant use disorder with an abbreviated version of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST; total score of 4 or more) OR reports using stimulants at least weekly in the past 3 months.
Lives in California or Florida with no plans to move out of state in the next 6 months
You may not be if
Unable or unwilling to provide informed consent
Unwilling to upload upload 3 video recordings of directly observed PrEP doses using a smartphone application
Identifies as transfeminine (e.g., transgender woman)
Unable or Unwilling to provide dried blood spot (DBS) specimen at baseline
Switched from daily oral PrEP with disoproxil fumarate (TDF) to daily oral PrEP with tenofovir alafenamide (TAF) in the past 5 months
Clareo Health | PrEP Affect Regulation Treatment Innovation
